Home/Filings/4/0001415889-24-026102
4//SEC Filing

MIDDLETON FRED A 4

Accession 0001415889-24-026102

CIK 0001534133other

Filed

Nov 4, 7:00 PM ET

Accepted

Nov 5, 3:04 PM ET

Size

16.1 KB

Accession

0001415889-24-026102

Insider Transaction Report

Form 4
Period: 2024-11-01
MIDDLETON FRED A
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2024-11-01$3.75/sh+86,867$325,751814,300 total(indirect: By Sanderling Venture Partners VI Co-Investment Fund, L.P.)
  • Purchase

    Common Stock

    2024-11-01$3.75/sh+877$3,28922,479 total(indirect: By Sanderling Ventures Management VI)
  • Purchase

    Common Stock

    2024-11-01$3.75/sh+20,000$75,00031,714 total
Holdings
  • Common Stock

    (indirect: By Sanderling Ventures Management VII)
    30,292
  • Common Stock

    (indirect: By Sanderling Ventures VII, L.P.)
    435,148
  • Common Stock

    (indirect: By LLC)
    8,176
  • Common Stock

    (indirect: By Sanderling VI Beteligungs GmbH & Co KG)
    7,456
  • Common Stock

    (indirect: By Partnership)
    8,884
  • Common Stock

    (indirect: By Sanderling Ventures VII (Canada), L.P.)
    114,260
  • Common Stock

    (indirect: By Sanderling Ventures VII Annex Fund, L.P.)
    27,609
  • Common Stock

    (indirect: By Sanderling Venture Partners VI, LP)
    946,744
Footnotes (5)
  • [F1]The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Venture Partners VI Co-Investment Fund, LP ("SVP VI Co-Investment, LP", together with Sanderling Venture Partners VI, LP., Sanderling VI Beteiligungs GmbH & Co. KG, Sanderling Ventures Management VI and Sanderling VI Limited Partnership (the "Sanderling VI Securities"). The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
  • [F2]The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the Sanderling VI Securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
  • [F3]The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Ventures VII, LP ("SVP VII, LP", together with Sanderling Ventures Management VII, Sanderling Ventures VII (Canada), L.P. and Sanderling Ventures VII Annex Fund, L.P., the "Sanderling VII Securities"). The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
  • [F4]The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the Sanderling VII Securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
  • [F5]The Reporting Person is a managing member of Golden Triangle Ventures LLC and may be deemed to beneficially own the securities of the Issuer held by Golden Triangle Ventures LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Issuer

CalciMedica, Inc.

CIK 0001534133

Entity typeother

Related Parties

1
  • filerCIK 0001267959

Filing Metadata

Form type
4
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 3:04 PM ET
Size
16.1 KB